{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T15:01:05Z","timestamp":1788966065339,"version":"build-2803163510"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2017,11,11]],"date-time":"2017-11-11T00:00:00Z","timestamp":1510358400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Vessels"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1007\/s00380-017-1072-6","type":"journal-article","created":{"date-parts":[[2017,11,11]],"date-time":"2017-11-11T10:12:16Z","timestamp":1510395136000},"page":"374-383","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Good response to tolvaptan shortens hospitalization in patients with congestive heart failure"],"prefix":"10.1007","volume":"33","author":[{"given":"Tomohito","family":"Kogure","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Jujo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuyuki","family":"Hamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsumi","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhisa","family":"Hagiwara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,11,11]]},"reference":[{"key":"1072_CR1","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1159\/000164149","volume":"113","author":"WF Peacock","year":"2009","unstructured":"Peacock WF, Costanzo MR, De Marco T, Lopatin M, Wynne J, Mills RM, Emerman CL (2009) Impact of intravenous loop diuretics on outcomes of patients hospitalized with acute decompensated heart failure: insights from the ADHERE registry. Cardiology 113:12\u201319","journal-title":"Cardiology"},{"key":"1072_CR2","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.ejheart.2007.07.011","volume":"9","author":"V Hasselblad","year":"2007","unstructured":"Hasselblad V, Gattis Stough W, Shah MR, Lokhnygina Y, O\u2019Connor CM, Califf RM, Adams KF Jr (2007) Relation between dose of loop diuretics and outcomes in a heart failure population: results of the ESCAPE trial. Eur J Heart Fail 9:1064\u20131069","journal-title":"Eur J Heart Fail"},{"key":"1072_CR3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0002-8703(02)94708-3","volume":"146","author":"CR Lee","year":"2003","unstructured":"Lee CR, Watkins ML, Patterson JH, Gattis W, O\u2019Connor CM, Gheorghiade M, Adams KF Jr (2003) Vasopressin: a new target for the treatment of heart failure. Am Heart J 146:9\u201318","journal-title":"Am Heart J"},{"key":"1072_CR4","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1001\/jama.297.12.1332","volume":"297","author":"M Gheorghiade","year":"2007","unstructured":"Gheorghiade M, Konstam MA, Burnett JC Jr, Grinfeld L, Maggioni AP, Swedberg K, Udelson JE, Zannad F, Cook T, Ouyang J, Zimmer C, Orlandi C (2007) Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials. JAMA 297:1332\u20131343","journal-title":"JAMA"},{"key":"1072_CR5","doi-asserted-by":"crossref","first-page":"F273","DOI":"10.1152\/ajprenal.00195.2005","volume":"290","author":"LC Costello-Boerrigter","year":"2006","unstructured":"Costello-Boerrigter LC, Smith WB, Boerrigter G, Ouyang J, Zimmer CA, Orlandi C, Burnett JC Jr (2006) Vasopressin-2-receptor antagonism augments water excretion without changes in renal hemodynamics or sodium and potassium excretion in human heart failure. Am J Physiol Renal Physiol 290:F273\u2013F278","journal-title":"Am J Physiol Renal Physiol"},{"key":"1072_CR6","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1007\/s00380-015-0775-9","volume":"31","author":"Y Uemura","year":"2016","unstructured":"Uemura Y, Shibata R, Takemoto K, Uchikawa T, Koyasu M, Ishikawa S, Mitsuda T, Miura A, Imai R, Iwamiya S, Ozaki Y, Kato T, Miura T, Watarai M, Murohara T (2016) Clinical benefit of tolvaptan in patients with acute decompensated heart failure and chronic kidney disease. Heart Vessels 31:1643\u20131649","journal-title":"Heart Vessels"},{"key":"1072_CR7","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s00380-016-0872-4","volume":"32","author":"A Hanatani","year":"2017","unstructured":"Hanatani A, Shibata A, Kitada R, Iwata S, Matsumura Y, Doi A, Sugioka K, Takagi M, Yoshiyama M (2017) Administration of tolvaptan with reduction of loop diuretics ameliorates congestion with improving renal dysfunction. Heart Vessels 32:287\u2013294","journal-title":"Heart Vessels"},{"key":"1072_CR8","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1253\/circj.CJ-12-0971","volume":"77","author":"T Imamura","year":"2013","unstructured":"Imamura T, Kinugawa K, Shiga T, Kato N, Muraoka H, Minatsuki S, Inaba T, Maki H, Hatano M, Yao A, Kyo S, Nagai R (2013) Novel criteria of urine osmolality effectively predict response to tolvaptan in decompensated heart failure patients\u2013association between non-responders and chronic kidney disease. Circ J 77:397\u2013404","journal-title":"Circ J"},{"key":"1072_CR9","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1253\/circj.CJ-13-0187","volume":"77","author":"N Sato","year":"2013","unstructured":"Sato N, Kajimoto K, Keida T, Mizuno M, Minami Y, Yumino D, Asai K, Murai K, Muanakata R, Aokage T, Sakata Y, Mizuno K, Takano T (2013) Clinical features and outcome in hospitalized heart failure in Japan (from the ATTEND Registry). Circ J 77:944\u2013951","journal-title":"Circ J"},{"key":"1072_CR10","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jchf.2014.09.003","volume":"3","author":"RJ Mentz","year":"2015","unstructured":"Mentz RJ, Stevens SR, DeVore AD, Lala A, Vader JM, AbouEzzeddine OF, Khazanie P, Redfield MM, Stevenson LW, O\u2019Connor CM, Goldsmith SR, Bart BA, Anstrom KJ, Hernandez AF, Braunwald E, Felker GM (2015) Decongestion strategies and renin-angiotensin-aldosterone system activation in acute heart failure. JACC Heart Fail 3:97\u2013107","journal-title":"JACC Heart Fail"},{"key":"1072_CR11","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1093\/eurheartj\/ehu065","volume":"35","author":"MA Valente","year":"2014","unstructured":"Valente MA, Voors AA, Damman K, Van Veldhuisen DJ, Massie BM, O\u2019Connor CM, Metra M, Ponikowski P, Teerlink JR, Cotter G, Davison B, Cleland JG, Givertz MM, Bloomfield DM, Fiuzat M, Dittrich HC, Hillege HL (2014) Diuretic response in acute heart failure: clinical characteristics and prognostic significance. Eur Heart J 35:1284\u20131293","journal-title":"Eur Heart J"},{"key":"1072_CR12","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ahj.2015.05.003","volume":"170","author":"JM Maaten Ter","year":"2015","unstructured":"Ter Maaten JM, Dunning AM, Valente MA, Damman K, Ezekowitz JA, Califf RM, Starling RC, van der Meer P, O\u2019Connor CM, Schulte PJ, Testani JM, Hernandez AF, Tang WH, Voors AA (2015) Diuretic response in acute heart failure-an analysis from ASCEND-HF. Am Heart J 170:313\u2013321","journal-title":"Am Heart J"},{"key":"1072_CR13","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1253\/circj.CJ-09-0254","volume":"73","author":"M Tsuchihashi-Makaya","year":"2009","unstructured":"Tsuchihashi-Makaya M, Hamaguchi S, Kinugawa S, Yokota T, Goto D, Yokoshiki H, Kato N, Takeshita A, Tsutsui H (2009) Characteristics and outcomes of hospitalized patients with heart failure and reduced vs preserved ejection fraction. Report from the Japanese cardiac registry of heart failure in cardiology (JCARE-CARD). Circ J 73:1893\u20131900","journal-title":"Circ J"},{"key":"1072_CR14","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1253\/circj.CJ-14-0244","volume":"78","author":"T Imamura","year":"2014","unstructured":"Imamura T, Kinugawa K, Fujino T, Inaba T, Maki H, Hatano M, Yao A, Komuro I (2014) Increased urine aquaporin-2 relative to plasma arginine vasopressin is a novel marker of response to tolvaptan in patients with decompensated heart failure. Circ J 78:2240\u20132249","journal-title":"Circ J"},{"key":"1072_CR15","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1007\/s00380-015-0780-z","volume":"31","author":"R Matsukawa","year":"2015","unstructured":"Matsukawa R, Kubota T, Okabe M, Yamamoto Y (2015) Early use of V2 receptor antagonists is associated with a shorter hospital stay and reduction in in-hospital death in patients with decompensated heart failure. Heart Vessels 31:1650\u20131658","journal-title":"Heart Vessels"},{"key":"1072_CR16","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1016\/j.jacc.2011.10.910","volume":"59","author":"GM Felker","year":"2012","unstructured":"Felker GM, Mentz RJ (2012) Diuretics and ultrafiltration in acute decompensated heart failure. J Am Coll Cardiol 59:2145\u20132153","journal-title":"J Am Coll Cardiol"},{"key":"1072_CR17","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S1388-9842(00)00094-5","volume":"2","author":"S Paterna","year":"2000","unstructured":"Paterna S, Di Pasquale P, Parrinello G, Amato P, Cardinale A, Follone G, Giubilato A, Licata G (2000) Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as a bolus, in refractory congestive heart failure. Eur J Heart Fail 2:305\u2013313","journal-title":"Eur J Heart Fail"},{"key":"1072_CR18","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.jjcc.2012.09.002","volume":"60","author":"K Watanabe","year":"2012","unstructured":"Watanabe K, Dohi K, Sugimoto T, Yamada T, Sato Y, Ichikawa K, Sugiura E, Kumagai N, Nakamori S, Nakajima H, Hoshino K, Machida H, Okamoto S, Onishi K, Nakamura M, Nobori T, Ito M (2012) Short-term effects of low-dose tolvaptan on hemodynamic parameters in patients with chronic heart failure. J Cardiol 60:462\u2013469","journal-title":"J Cardiol"},{"key":"1072_CR19","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1253\/circj.CJ-66-0093","volume":"78","author":"K Kinugawa","year":"2014","unstructured":"Kinugawa K, Sato N, Inomata T, Shimakawa T, Iwatake N, Mizuguchi K (2014) Efcacy and safety of tolvaptan in heart failure patients with volume overload\u2014an interim result of post-marketing surveillance in Japan. Circ J 78:844\u2013852","journal-title":"Circ J"},{"key":"1072_CR20","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1007\/s00228-016-2091-4","volume":"72","author":"K Hirai","year":"2016","unstructured":"Hirai K, Shimomura T, Moriwaki H, Ishii H, Shimoshikiryo T, Tsuji D, Inoue K, Kadoiri T, Itoh K (2016) Risk factors for hypernatremia in patients with short- and long-term tolvaptan treatment. Eur J Clin Pharmacol 72:1177\u20131183","journal-title":"Eur J Clin Pharmacol"}],"updated-by":[{"DOI":"10.1007\/s00380-017-1102-4","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2017,12,12]],"date-time":"2017-12-12T00:00:00Z","timestamp":1513036800000}}],"container-title":["Heart and Vessels"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00380-017-1072-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00380-017-1072-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00380-017-1072-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,3,20]],"date-time":"2018-03-20T12:57:26Z","timestamp":1521550646000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00380-017-1072-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,11]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["1072"],"URL":"https:\/\/doi.org\/10.1007\/s00380-017-1072-6","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s00380-017-1102-4","asserted-by":"object"}]},"ISSN":["0910-8327","1615-2573"],"issn-type":[{"value":"0910-8327","type":"print"},{"value":"1615-2573","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,11]]}}}